What is GXAI's health score?

GAXOS.AI INC. (GXAI) has a TradeApes health score of 36 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is GXAI's estimated fair value?

Based on our 5-year discounted cash flow model, GAXOS.AI INC.'s estimated fair value is $0.74 per share, representing a -44.6% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is GXAI undervalued or overvalued?

Our model currently rates GXAI as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for GXAI... Refresh in a moment for the full analysis.

GAXOS.AI INC. (GXAI)

Technology Overvalued low weak

$1.35

Updated: 2026-06-04

TradeApes Score

Financial Strength

40 Weak

Operating Trend

30 Weak

Relative Value

40 Weak

Capital Allocation

10 Stressed

Risk

65 Healthy

Est. Fair Value $0.74

DCF Upside -44.6%

Sector Rank #2028 of 7713

Key Findings

+ Strong liquidity — current assets more than 2× current liabilities

Unlock Full Report →

− Significant dilution — share count up more than 5% year over year

Unlock Full Report →

2 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.